Skip to content

We’re hiring doctors! Learn more

ADHD rules by state

ADHD rules in Northern Territory

In the Northern Territory, an adult can only be started on stimulant medicine for ADHD by a specialist psychiatrist, neurologist or physician, or by a registrar training in one of those fields; there is no NT pathway that allows a GP to start it, and none had been published as at 21 August 2026. A GP can take over the ongoing prescribing afterwards, but only in shared care with that specialist, only with their own written approval from the NT Chief Health Officer for that individual patient, only while the specialist reviews the patient at least once every two years, and - under NT Health's published code - only for up to 10 such patients at a time. NT Health's own page also says a specialist may begin supply without an approval and must obtain one if supply goes beyond 30 days, which does not sit with the same page's rule that approval is required before a prescription is issued; NT Health's Medicines and Poisons Control section on (08) 8922 7341 is the place to have that resolved.

Last checked 2026-08-21. These rules change, sometimes at short notice. We date every page and cite the source we used, so you can check it yourself. Nothing here is advice about your own treatment — your prescriber and your state health department are the authorities on that.

Who can diagnose you

Who is allowed to make the diagnosis here?

Northern Territory medicines law regulates who may prescribe, not who may diagnose. Nothing in the Medicines, Poisons and Therapeutic Goods Act 2012 (NT), its Regulations or NT Health's Schedule 8 Code of Practice says who may make an ADHD diagnosis in an adult. The gate that does exist sits at treatment: for a person aged 18 or over, the clinical decision to start stimulant ADHD medicine must be made by a specialist psychiatrist, neurologist or physician, or by a registrar in training in one of those disciplines, so an assessment by a GP or a psychologist alone does not satisfy the NT prescribing requirement.

Full-text searches of the Act (reprint in force 10 February 2026), the Regulations (reprint in force 1 May 2026) and the Code of Practice (Volume 1, Version 1.0, 7 June 2018) return no provision on who may diagnose ADHD. The one ADHD-specific provision is regulation 41, headed 'Duration of Schedule 8 authorisation for treating child's ADHD', which provides that such an authorisation remains in force until the child becomes an adult. The Chief Health Officer's application form (Appendix B) lists 'Adult Attention Deficit Disorder' as a diagnosis category, and confines the 'specialist initiating or reviewing patient' category boxes to Paediatrician, Neurologist, Psychiatrist, Physician and Registrar; the Code (Part 3.3) then bars specialist paediatricians and their registrars from initiating supply for a patient who has attained 18 years, which is why the adult list reduces to psychiatrist, neurologist, physician or registrar in training. Currency caveat that belongs on any published page: Part 3 of the Code still describes a 'declared medical condition' regime under section 247 of the Act (under which attention deficit disorder was a declared condition). Sections 247 and 248 were repealed with effect from 10 December 2022, and under the Act as in force the authorised purpose for a restricted Schedule 8 substance is simply 'therapeutic use' (s 5). We reviewed NT Health's medicines and poisons pages and could not locate any NT Health adult ADHD assessment or diagnostic guidance; NT Health's own site search could not be used as evidence because it returns unrelated whole-of-government results.

Who can start treatment

Who can start you on medicine, and what approval do they need?

For an adult, only a specialist psychiatrist, neurologist or physician - or a registrar in training in one of those disciplines who is resident in the Northern Territory and working within a supervised training environment - may make the decision to start stimulant ADHD medicine. General practitioners and nurse practitioners cannot initiate, and there is no GP-initiation pathway in the Northern Territory as at 21 August 2026. The general rule is that the prescriber must hold a Schedule 8 authorisation issued by the NT Chief Health Officer for that individual patient before a prescription is issued; NT Health also publishes a conflicting statement about the first 30 days, set out below, which its own materials do not reconcile.

Section 85 of the Act makes it a strict liability offence (maximum 100 penalty units) to issue a prescription for a restricted Schedule 8 substance unless the practitioner issues it 'under a Schedule 8 authorisation, or Schedule 8 exemption, for an authorised purpose'; section 139(1)(c)(ii) is the power under which the Chief Health Officer issues that authorisation. Applications are made on the Appendix B form to NT Health Medicines and Poisons Control (poisonscontrol@nt.gov.au, (08) 8922 7341). THE CONFLICT, which a published page should disclose rather than resolve: NT Health's Schedule 8 page states in one bullet that 'authorisation from the CHO is required for each individual patient before a prescription can be issued' and in another that 'specialists may initiate supply without an authorisation, but must obtain an authorisation if supply exceeds 30 days'. NT Health's Pharmacists page states without qualification that 'Prescribers are required to obtain authorisation before prescribing these substances', and the Code (Part 3.2) says prescribers 'must be authorised to do so by the CHO' with no 30-day carve-out anywhere in its 49 pages. The Act does permit the Chief Health Officer to exempt a class of practitioners by notice (s 245), but NT Health's published index of in-force notices lists only two psychostimulant exemptions - an emergency-response exemption of 7 December 2021 and a group-practice/locum exemption gazetted 30 April 2014 - and neither is described as a general 30-day initiation exemption. We could not retrieve the gazette itself (nt.gov.au returns HTTP 403 to automated retrieval). Anyone relying on the point should confirm it with NT Medicines and Poisons Control on (08) 8922 7341. Other requirements that apply on initiation: the prescriber must check the NTScript monitored medicines database before issuing the prescription (s 243J, strict liability, maximum 50 penalty units, subject to circumstances prescribed as exempt by reg 81F - aged care residents and prisoners in custodial correctional facilities - and a reasonable excuse defence); a prescription may allow up to six months total supply, with no more than one month dispensed at a time unless the Chief Health Officer has given prior written authorisation; a change between these medicines, and cessation, must be notified in writing within 14 days on the same form. SCOPE: this framework attaches to the stimulant medicines declared to be restricted Schedule 8 substances in the NT. It does not by its terms reach medicines used for ADHD that are not Schedule 8 substances, and the NTScript check-before-prescribing duty is likewise confined to Schedule 8 substances plus the short list of other medicines prescribed by reg 81C, which does not include any non-stimulant ADHD medicine - see 'unconfirmed' before relying on that. Separately, the pharmacist-prescriber provision inserted on 1 May 2026 (reg 7AB) is confined to UNRESTRICTED Schedule 4 and Schedule 8 substances and does not extend to these medicines.

Who can continue it

Once you are stable, who can keep prescribing?

After a specialist has started treatment, another medical practitioner registered and practising in the Northern Territory - in practice a GP - may continue prescribing, but only as co-management, not as independent care. The continuing prescriber must hold their own Chief Health Officer authority for that individual patient, renew it every two years with a declaration that a specialist has reviewed the patient in the past two years, and the specialist (or their registrar in training) must review the patient at least every 24 months. NT Health's published code also limits a non-specialist prescriber to 10 such patients at a time.

The Code (Part 3.3) requires the continuing prescriber to complete a formal declaration that the patient has recently been reviewed by the specialist or their registrar, including the specialist's name and address; the Appendix B form carries those fields plus a mandatory field recording whether the prescriber has personally verified the decision with the specialist. Part 3.4 caps the arrangement at six months where the initiating specialist is based interstate or overseas, within which the patient must be reviewed by an NT-based specialist paediatrician, neurologist, psychiatrist, physician or registrar in training; the Code does not define 'NT based'. Part 3.3 also requires the NT prescriber to personally verify the initiation decision with an interstate specialist rather than rely solely on a letter carried by the patient, and states that letters from interstate registrars will not be accepted. THE PATIENT CAPS ARE PUBLISHED POLICY, NOT A LOCATABLE STATUTORY LIMIT: Part 3.10 sets the numbers at 200 for a specialist and 10 for a nurse practitioner or non-specialist medical practitioner and attributes both to section 85 of the Act, but section 85 as in force contains no patient-number mechanism and the phrase 'prescribed number of persons' appears nowhere in the Act (10 February 2026) or the Regulations (1 May 2026). A prescriber may apply in writing to the Chief Health Officer to exceed the number, and the application is referred to the Committee for advice. Whether a nurse practitioner may co-prescribe for an ADULT in the NT is genuinely unresolved between NT Health's own sources - see 'unconfirmed'. NT Health's notices index also lists an in-force exemption titled 'Prescribe psychostimulant in absence of authorised specialised prescriber in group practice/as locum' (gazetted 30 April 2014), whose operative terms we could not read.

Telehealth

Can this happen by video, and does the practitioner have to be here?

Northern Territory medicines law imposes no in-person, face-to-face or physical-examination requirement, and contains no telehealth rule, for assessment or for prescribing these medicines. The NT conditions are the same however the consultation happens: the initiation decision must be a specialist's, the prescriber must hold the per-patient Chief Health Officer authority, and NTScript must be checked before the prescription is issued. What governs the mode of consultation is a national professional standard set by the Medical Board of Australia. Those guidelines are made under section 39 of the Health Practitioner Regulation National Law - they are the standard a practitioner's conduct is assessed against, not legislation, and should not be described as law.

We searched the full text of the Act (10 February 2026), the Regulations (1 May 2026) and the Code of Practice (7 June 2018) for 'telehealth', 'in person', 'in-person', 'face-to-face', 'physical examination' and 'video': there are no relevant occurrences in any of the three. This is an absence of any NT requirement, not an NT statement permitting telehealth. The Medical Board's guidelines state that telehealth 'should not be considered as a routine substitute for in-person consultations', that video consultations are preferable to telephone where practical, and that telehealth 'is generally most appropriate in the context of a continuing clinical relationship with a patient that also involves in-person consultations'. They also expressly recognise the role of telehealth in rural and remote settings and state that they 'do not prevent or discourage one-off telehealth consultations'. On prescribing, the guidelines state that prescribing or providing healthcare for a patient without a real-time direct consultation - including asynchronous requests based on the patient completing a health questionnaire where the practitioner has never spoken with the patient - 'is not good practice and is not supported by the Board', while also recognising 'that it may be appropriate for a patient's usual medical practitioner or another health practitioner with access to the patient's clinical record to prescribe without a consultation in certain circumstances'. The Board expects practitioners consulting patients located in Australia to be registered with it, and to be aware of and comply with state and territory legislative requirements when prescribing, including using the relevant real-time prescription monitoring service - in the NT, NTScript, which patients cannot opt out of. Medicare and MBS telehealth eligibility rules are a separate national question and were not researched for this page.

If you move here

What happens to a diagnosis and treatment from another state?

An approval or permit issued in another state or territory has no effect in the Northern Territory. A new NT prescriber must obtain their own Chief Health Officer authority for that individual patient before prescribing. A prescription for these medicines written by an interstate prescriber can be dispensed in the NT only where the prescriber is of a specialty that would ordinarily be endorsed to initiate treatment in the Territory; for a patient aged 18 or over that means a psychiatrist, neurologist or physician, because the Code bars specialist paediatricians and their registrars from initiating for a person who has turned 18. A prescription for these medicines written by an interstate GP or nurse practitioner does not fall within that description.

NT Health's Pharmacists page states that prescriptions for these restricted Schedule 8 stimulant medicines written by interstate prescribers 'can be dispensed in the NT where the prescriber would normally be endorsed to initiate treatment in the Territory', listing paediatricians, psychiatrists, neurologists and physicians, and notes that prescriber qualifications can be checked on the AHPRA register. Regulation 7A(b) sets the conditions a pharmacist must verify in that situation: the identity of the person presenting the prescription, the validity of the prescription, and the specialty of the interstate prescriber. Regulation 7A is not the only route - section 58(2) of the Act allows supply on an interstate prescription either in accordance with the prescribed conditions or under an approval given under section 253, and NT Health lists an in-force approval titled 'Approval for Pharmacist to Supply S8 Substances on Interstate Prescription (Cross-Border Communities)' gazetted 23 April 2014. For ongoing treatment, the Code (Part 3.4) allows an NT-based general medical practitioner or nurse practitioner relying on an interstate or overseas specialist to supply for a maximum of six months only, within which the patient must be reviewed by an NT-based specialist; the NT prescriber must personally verify the initiation decision with the interstate specialist rather than rely solely on a letter carried by the patient, and letters from interstate registrars are not accepted. For a person arriving from overseas, the Code requires the NT practitioner to contact the person's previous doctor by telephone, fax or email to verify the history and to complete the Appendix B application; once the authorisation is approved, an international visitor in the NT for less than three months may be supplied only one prescription with a maximum of one repeat, while a person residing in the NT for longer than three months may be supplied an appropriate prescription. For a person who was treated as a child, regulation 41 provides that a Schedule 8 authorisation for treating a child's ADHD remains in force only until the child becomes an adult, and the Code adds that on the patient's 18th birthday the paediatrician must either renew the authority or transfer care to an adult specialist.

What we could not confirm

We went looking for these and could not find a primary source. We would rather show you the gap than fill it with something that sounds right. Take these to your prescriber or the department directly.

  • THE 30-DAY STATEMENT. NT Health's Schedule 8 page states that 'specialists may initiate supply without an authorisation, but must obtain an authorisation if supply exceeds 30 days', while the same page, NT Health's Pharmacists page and the Code of Practice all state that authorisation is required before prescribing. We could not trace the 30-day statement to any legal instrument: it appears nowhere in the Act (10 February 2026), the Regulations (1 May 2026) or the 49-page Code, and NT Health's index of in-force notices lists only two psychostimulant exemptions, neither described as a general specialist exemption. Section 245 does allow class exemptions, and one reviewer reported locating a 2014 gazetted class exemption for specialists with a 30-day condition in NT Government Gazette G17 of 2014; we could not retrieve that gazette (nt.gov.au returns HTTP 403 to automated retrieval) and NT Health's in-force index does not list such a notice. Publish the conflict, not a resolution, and direct readers to NT Medicines and Poisons Control on (08) 8922 7341.
  • THE OPERATIVE TERMS OF TWO IN-FORCE EXEMPTIONS. 'Exemption - S8 authorisation - During Emergency response - Medical practitioners and nurse practitioners Psychostimulants' (7 December 2021) and 'Exemption - S8 Authorisation - Prescribe psychostimulant in absence of authorised specialised prescriber in group practice/as locum' (30 April 2014) are both listed by NT Health as in force, but the gazette PDFs could not be retrieved. Whether the emergency exemption is presently operative, and exactly who the locum/group-practice exemption covers, are unresolved.
  • THE STATUTORY BASIS OF THE PATIENT CAPS. The Code sets caps of 200 patients (specialist) and 10 patients (nurse practitioner or non-specialist medical practitioner) 'pursuant to section 85 of the Act'. Section 85 as in force contains no patient-number mechanism and the phrase 'prescribed number of persons' appears nowhere in the Act or the Regulations. The caps are reported here as the regulator's published policy, applied through authorisation conditions; their present statutory basis is unclear.
  • THE CURRENCY OF THE GOVERNING CODE. The operative Code of Practice is Volume 1, Version 1.0, dated 7 June 2018, with a Document Control table recording CHO approval on 21 March 2014, and it still describes the 'declared medical condition' regime under section 247 of the Act, which was repealed on 10 December 2022. NT Health has separately reissued Parts 4 and 4B but not the psychostimulant Part 3. Whether NT Health treats the 2018 declared-condition list as still operative, and whether a replacement instrument exists, could not be confirmed.
  • NURSE PRACTITIONERS AND ADULT PATIENTS. The Code's competence test recognises 'a nurse practitioner whose scope of practice is paediatrics', which on its face supplies no route for adult care, while NT Health's Pharmacists page states without qualification that general medical practitioners and nurse practitioners can co-prescribe with a specialist, and the Appendix B form carries a 'Nurse Prac.' prescriber box with a co-prescribing footnote naming adult specialties. NT Health's own sources conflict and we could not resolve it.
  • INTERSTATE SPECIALISTS AND THE NT AUTHORITY. NT documents address the dispensing side only. Whether an interstate specialist who is not physically in the NT may themselves hold an NT Chief Health Officer authority, or needs one to prescribe for a patient located in the NT, is not stated by NT Health and could not be resolved from the Act.
  • THE MEANING OF 'NT BASED'. The Code caps the co-prescribing arrangement at six months where the specialist is 'based interstate or overseas' and requires review by an 'NT based' specialist, but does not define the term. Whether a specialist physically located in another state who consults by video can satisfy it is unresolved, and it is the question most likely to decide whether an arrangement survives a move.
  • NON-STIMULANT ADHD MEDICINES. The NT authority framework described on this page attaches to the stimulant medicines declared to be restricted Schedule 8 substances, and the NTScript check-before-prescribing duty attaches to Schedule 8 substances plus a short list of other medicines prescribed by regulation 81C that contains no ADHD medicine. We did NOT verify, against the current Poisons Standard as adopted in the NT, that every non-stimulant medicine used for ADHD sits outside Schedule 8, and we did not research PBS or Medicare subsidy conditions, which are a separate national question and may themselves involve specialist requirements. Do not state or imply an NT position on non-stimulant medicines beyond the fact that the restricted Schedule 8 authority framework is written for the stimulant category.
  • CLAIMS OF A FEBRUARY 2026 NT GP PATHWAY. Assertions circulating on commercial telehealth and ADHD marketing sites that from February 2026 NT GPs who complete training and notify the Chief Health Officer may prescribe under a 'standing CHO approval' could not be verified. No such notice, gazette, form or page appears on NT Health's medicines and poisons pages, in the Act (reprint in force 10 February 2026), in the Regulations (reprint in force 1 May 2026), or in NT Health's index of in-force notices, whose most recent psychostimulant entry is dated 7 December 2021. Do not repeat it. The only 2026 NT prescribing change we found - a pharmacist-prescriber provision commencing 1 May 2026 - is confined to unrestricted Schedule 4 and 8 substances and does not touch these medicines.
  • WAIT TIMES AND PUBLIC ASSESSMENT. We could not confirm any published wait time for adult ADHD assessment in the Northern Territory, public or private, and NT Health publishes no adult ADHD service page. A researcher's inference that adults cannot obtain an ADHD assessment in the NT public system rests on the published scope of Top End Mental Health Services plus the absence of any NT public ADHD service page; the Central Australia service scope was not checked, and workforce-supply figures cited in research were not independently re-verified. Publish no number.
  • PAGE CURRENCY AND ACCESS. None of the three NT Health pages relied on carries a published last-updated or last-reviewed date, and health.nt.gov.au and nt.gov.au return HTTP 403 to automated retrieval. Their content was verified from Internet Archive captures dated 3 December 2025, so the live pages could have changed between that date and 21 August 2026. Readers auditing citations to health.nt.gov.au will need a normal browser.
  • CONTINUITY WHEN A PRESCRIBER CHANGES. The mechanics are confirmed (the outgoing prescriber notifies the Chief Health Officer within 14 days; the incoming prescriber must obtain their own per-patient authority; the 10-patient cap applies to the incoming non-specialist). Whether NT Health operates any bridging arrangement to prevent a gap in supply, and the typical processing time for an application, are not published and could not be confirmed.

What changed recently

  1. 2021-12-16

    Part 7.1AA was inserted into the Act by the Medicines, Poisons and Therapeutic Goods Legislation Amendment Act 2021 (Act No. 27, 2021, assented 15 December 2021, commenced 16 December 2021), creating the NT monitored medicines database (NTScript) and making it a strict liability offence for a prescriber to issue a prescription for a monitored medicine without first checking the database (s 243J, maximum 50 penalty units) and for a pharmacist to supply one without checking (s 243K). Schedule 8 substances, which include these stimulant medicines, are monitored medicines.

    Northern Territory Government (legislation.nt.gov.au) — Medicines, Poisons and Therapeutic Goods Act 2012 (NT) - reprint PDF, ss 243A-243K and endnotes

  2. 2022-12-10

    The Medicines, Poisons and Therapeutic Goods Legislation Amendment Act 2022 (Act No. 25, 2022, assented 9 December 2022) commenced, repealing ss 247 and 248 - the 'declared medical condition' mechanism under which the Chief Health Officer had declared by gazette notice the conditions (including attention deficit disorder) for which these medicines could be prescribed. Under the Act as in force, the authorised purpose for a restricted Schedule 8 substance simply includes 'therapeutic use' (s 5). NT Health's Schedule 8 Code of Practice, still published as Version 1.0 dated 7 June 2018, continues to describe the repealed mechanism. The authorisation requirement itself was unaffected; it rests on ss 85 and 139.

    Northern Territory Government (legislation.nt.gov.au) — Medicines, Poisons and Therapeutic Goods Act 2012 (NT) - reprint PDF, s 5 and endnotes ('ss 247 - 248 rep No. 25, 2022, s 43')

  3. 2026-02-10

    The current reprint of the Act commenced, following the Statute Law Revision and Repeals Act 2026 (Act No. 3, 2026, assented 9 February 2026). Its amendments to this Act (ss 110, 228 and 236) are formal statute-law-revision changes and do not touch the ADHD prescribing framework.

    Northern Territory Government (legislation.nt.gov.au) — Medicines, Poisons and Therapeutic Goods Act 2012 (NT) - reprint PDF, endnotes

  4. 2026-05-01

    The Medicines, Poisons and Therapeutic Goods Amendment Regulations 2026 (SL No. 11 of 2026, made 30 April 2026) commenced, inserting regulation 7AB so that a pharmacist who has completed pharmacist prescriber training may issue prescriptions. This is confined to UNRESTRICTED Schedule 4 and Schedule 8 substances and does not extend to the restricted Schedule 8 stimulant medicines used for ADHD. It is noted here because it is the change most likely to be mistaken for an NT ADHD reform.

    Northern Territory Government (legislation.nt.gov.au) — Medicines, Poisons and Therapeutic Goods Regulations 2014 (NT) - reprint PDF, reg 7AB and endnotes

  5. 2026-08-21

    NO NT ADHD PRESCRIBING REFORM FOUND, and none is recorded as announced or commencing later. Unlike several other Australian jurisdictions that changed their rules between 2023 and 2026, the NT has published no GP-initiation or GP-continuation training pathway. NT Health's Schedule 8 Code of Practice remains Version 1.0 dated 7 June 2018; its index of in-force notices contains no psychostimulant entry after 7 December 2021; and the Act and Regulations reprints in force contain no relevant amendment.

    NT Health (via Internet Archive) — Medicines and poisons notices; Medical practitioners and schedule 8 medicines

Available across Australia by telehealth.

Is Seen right for you?Compare all states